Breaking News
Get 50% Off 0
🏄 Grow your portfolio even on vacation with InvestingPro | Summer Sale 50% OFF
CLAIM SALE
Close

Shanghai Medicilon Inc (688202)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
64.20 +0.08    +0.12%
07:59:59 - Closed. Currency in CNY
Type:  Equity
Market:  China
ISIN:  CNE100003NQ8 
  • Volume: 10,049,178
  • Bid/Ask: 64.15 / 64.25
  • Day's Range: 63.15 - 66.49
Shanghai Medicilon 64.20 +0.08 +0.12%

Shanghai Medicilon Inc Company Profile

 
Get an in-depth profile of Shanghai Medicilon Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

2349

Equity Type

ORD

Shanghai Medicilon Inc., a contract research organization, provides drug discovery and development services to pharmaceutical and biotechnology companies in China and internationally. The company operates through Drug Discovery and Pharmaceutical Research, and Preclinical Research segments. It offers medicinal and analytical chemistry; process development services; custom and zoom in synthesis; structural, in vitro, and computational biology; protein expression and purification; protein crystallization; and recombinant kinase preparation services, as well as protein target validation, compound activity screening and optimization, raw material and preparation process research, and quality standards and stability research. The company also provides process route screening, API production process optimization, drug process research and application, pharmacology services, drug safety evaluation, biological analysis, IND filing, and TCM preclinical trial service solutions, such as pharmaceutical research, pharmacodynamics, pharmacokinetics, and toxicology. In addition, it provides efficient lipid synthesis, liposome preparation, prescription screening, process optimization and development, quality research, safety evaluation, bioanalysis, registration and declaration, etc.; pre-formulation research, drug analysis, drug stability research, and formulation development; and cytokine and biomarker testing, bioanalysis, and flow cytometry service, as well as assists in the research and development of new drugs. Further, the company is involved in molecular type drug development activities. Shanghai Medicilon Inc. was founded in 2004 and is headquartered in Shanghai, China.

Contact Information

Address No. 585, Chuanda Road Pudong New Area
Shanghai, 201299
China
Phone 86 21 5859 1500
Fax 86 21 5859 6369

Top Executives

Name Age Since Title
Qingcong Lin 60 2024 Deputy GM & Director
Chun-Lin Chen 63 2004 Co-Founder, Chairman & CEO
Weichun Jin 53 2016 Supervisor
Jinna Cai 61 2021 Chief Commercial Officer, Deputy GM & Director
Weidong Lai 67 2021 Independent Director
Dawei Ma 62 2021 Independent Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

688202 Comments

Write your thoughts about Shanghai Medicilon Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email